During the past decade, Ospedale degli Infermi conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 5 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 5 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale degli Infermi" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Biogen" with 2 trials sponsored, "Egetis Therapeutics" with 2 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials sponsored and "Fondazione Italiana Linfomi ONLUS" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale degli Infermi" #1 collaborator was "Gruppo Oncologico Italiano di Ricerca Clinica" with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 2 trials as a collaborator, "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 2 trials as a collaborator and "Istituto Di Ricerche Farmacologiche Mario Negri" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale degli Infermi" are "Diffuse Large B-Cell Lymphoma" (3 trials), "Alzheimer's Disease" (2 trials), "Chemotherapy-induced Peripheral Neuropathy" (2 trials), "Colorectal Cancer" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Ospedale degli Infermi" in a lesser frequency.

Most popular intervention types in "Ospedale degli Infermi" are "Drug" (23 trials), "Other" (6 trials), "Procedure" (6 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Prednisone" (3 trials), "Rituximab" (3 trials), "Bevacizumab" (2 trials) and "Calmangafodipir (5 µmol/kg)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale degli Infermi" are 25 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale degli Infermi". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Ospedale degli Infermi, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale degli Infermi, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".